yoteki

Tech&Science

Tech&Science

FDA Rejects Radiopharmaceutical Therapy Expected to Rival Novartis

STAT News

In a surprise decision, the FDA has rejected a new radiopharmaceutical therapy due to manufacturing issues, halting a potential competitor to Novartis's dominant treatment.

That's all the important news for now

Everything above cleared the significance threshold. You're free.